2022
DOI: 10.1002/tox.23532
|View full text |Cite|
|
Sign up to set email alerts
|

LINC00365 inhibited lung adenocarcinoma progression and glycolysis via sponging miR‐429/KCTD12 axis

Abstract: This study researched the function of long non-coding RNA LINC00365 in lung adenocarcinoma (LAD) progression. LINC00365, miR-429, and KCTD12 expression in the LAD clinical tissues and cells were detcetd by qRT-PCR and Western blot. LINC00365, miR-429, and KCTD12 effects on H1975 cells malignant phenotype were detected by cell counting kit-8 assay, clone formation experiment, Transwell experiment, and glycolysis. Dual luciferase reporter gene assay and RNA pull-down assay were implemented. LINC00365 effect on H… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 52 publications
(95 reference statements)
0
2
0
Order By: Relevance
“…LINC00365 could be a potential candidate for targeted therapy of lung adenocarcinoma clinically. [ 24 ] The role of LINC00365 in inhibiting or promoting EC has not been studied, but our result showed it was significantly lower expressed in EC patients. The expression of TMEM75 was upregulated in colorectal cancer tissues compared with nontumor tissues and positively correlated with the advanced clinical stage.…”
Section: Discussionmentioning
confidence: 82%
“…LINC00365 could be a potential candidate for targeted therapy of lung adenocarcinoma clinically. [ 24 ] The role of LINC00365 in inhibiting or promoting EC has not been studied, but our result showed it was significantly lower expressed in EC patients. The expression of TMEM75 was upregulated in colorectal cancer tissues compared with nontumor tissues and positively correlated with the advanced clinical stage.…”
Section: Discussionmentioning
confidence: 82%
“…KCTD12 is an emerging biomarker for sarcoma that has been demonstrated by immunohistochemistry in multi-center studies on patients with clinical sarcoma 19 . KCTD12 can combine with miRNAs as the information transmission axis component of LINC00365 to regulate glycolysis in LUAD cells, thereby affecting the progression of LUAD 20 . KCTD12 inhibits the proliferation and invasion of UVM and ESCA as well as the growth of xenograft tumors.…”
Section: Discussionmentioning
confidence: 99%